Annual Revenue
$56.33 B
+$2.02 B+3.71%
December 1, 2024
Summary
- As of February 7, 2025, ABBV annual revenue is $56.33 billion, with the most recent change of +$2.02 billion (+3.71%) on December 1, 2024.
- During the last 3 years, ABBV annual revenue has risen by +$137.00 million (+0.24%).
- ABBV annual revenue is now -2.96% below its all-time high of $58.05 billion, reached on December 31, 2022.
Performance
ABBV Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$15.10 B
+$642.00 M+4.44%
December 1, 2024
Summary
- As of February 7, 2025, ABBV quarterly revenue is $15.10 billion, with the most recent change of +$642.00 million (+4.44%) on December 1, 2024.
- Over the past year, ABBV quarterly revenue has increased by +$642.00 million (+4.44%).
- ABBV quarterly revenue is now -0.13% below its all-time high of $15.12 billion, reached on December 31, 2022.
Performance
ABBV Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$56.33 B
+$801.00 M+1.44%
December 1, 2024
Summary
- As of February 7, 2025, ABBV TTM revenue is $56.33 billion, with the most recent change of +$801.00 million (+1.44%) on December 1, 2024.
- Over the past year, ABBV TTM revenue has increased by +$801.00 million (+1.44%).
- ABBV TTM revenue is now -2.96% below its all-time high of $58.05 billion, reached on December 31, 2022.
Performance
ABBV TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ABBV Revenue Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +3.7% | +4.4% | +1.4% |
3 y3 years | +0.2% | +3.6% | -1.8% |
5 y5 years | +69.3% | +73.5% | +69.3% |
ABBV Revenue Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -3.0% | +3.7% | -0.1% | +23.5% | -3.0% | +3.7% |
5 y | 5-year | -3.0% | +69.3% | -0.1% | +75.2% | -3.0% | +69.3% |
alltime | all time | -3.0% | +296.3% | -0.1% | +287.6% | -3.0% | +1345.7% |
AbbVie Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $56.33 B(+3.7%) | $15.10 B(+4.4%) | $56.33 B(+1.4%) |
Sep 2024 | - | $14.46 B(-0.0%) | $55.53 B(+1.0%) |
Jun 2024 | - | $14.46 B(+17.5%) | $55.00 B(+1.1%) |
Mar 2024 | - | $12.31 B(-13.9%) | $54.40 B(+0.2%) |
Dec 2023 | $54.32 B(-6.4%) | $14.30 B(+2.7%) | $54.32 B(-1.5%) |
Sep 2023 | - | $13.93 B(+0.4%) | $55.14 B(-1.6%) |
Jun 2023 | - | $13.87 B(+13.4%) | $56.02 B(-1.3%) |
Mar 2023 | - | $12.22 B(-19.2%) | $56.74 B(-2.3%) |
Dec 2022 | $58.05 B(+3.3%) | $15.12 B(+2.1%) | $58.05 B(+0.4%) |
Sep 2022 | - | $14.81 B(+1.6%) | $57.82 B(+0.8%) |
Jun 2022 | - | $14.58 B(+7.7%) | $57.35 B(+1.1%) |
Mar 2022 | - | $13.54 B(-9.1%) | $56.73 B(+0.9%) |
Dec 2021 | $56.20 B(+22.7%) | $14.89 B(+3.8%) | $56.20 B(+1.9%) |
Sep 2021 | - | $14.34 B(+2.7%) | $55.17 B(+2.7%) |
Jun 2021 | - | $13.96 B(+7.3%) | $53.73 B(+7.0%) |
Mar 2021 | - | $13.01 B(-6.1%) | $50.20 B(+9.6%) |
Dec 2020 | $45.80 B(+37.7%) | $13.86 B(+7.4%) | $45.80 B(+12.7%) |
Sep 2020 | - | $12.90 B(+23.8%) | $40.65 B(+12.2%) |
Jun 2020 | - | $10.43 B(+21.0%) | $36.23 B(+6.4%) |
Mar 2020 | - | $8.62 B(-1.0%) | $34.06 B(+2.4%) |
Dec 2019 | $33.27 B(+1.6%) | $8.70 B(+2.7%) | $33.27 B(+1.2%) |
Sep 2019 | - | $8.48 B(+2.7%) | $32.87 B(+0.7%) |
Jun 2019 | - | $8.26 B(+5.5%) | $32.62 B(-0.1%) |
Mar 2019 | - | $7.83 B(-5.7%) | $32.65 B(-0.3%) |
Dec 2018 | $32.75 B(+16.1%) | $8.30 B(+0.8%) | $32.75 B(+1.8%) |
Sep 2018 | - | $8.24 B(-0.5%) | $32.19 B(+4.0%) |
Jun 2018 | - | $8.28 B(+4.3%) | $30.95 B(+4.5%) |
Mar 2018 | - | $7.93 B(+2.5%) | $29.61 B(+4.9%) |
Dec 2017 | $28.22 B | $7.74 B(+10.6%) | $28.22 B(+3.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2017 | - | $7.00 B(+0.7%) | $27.27 B(+2.1%) |
Jun 2017 | - | $6.94 B(+6.2%) | $26.71 B(+1.9%) |
Mar 2017 | - | $6.54 B(-3.8%) | $26.22 B(+2.3%) |
Dec 2016 | $25.64 B(+12.2%) | $6.80 B(+5.7%) | $25.64 B(+1.6%) |
Sep 2016 | - | $6.43 B(-0.3%) | $25.24 B(+2.0%) |
Jun 2016 | - | $6.45 B(+8.3%) | $24.75 B(+4.1%) |
Mar 2016 | - | $5.96 B(-6.9%) | $23.78 B(+4.0%) |
Dec 2015 | $22.86 B(+14.5%) | $6.40 B(+7.7%) | $22.86 B(+4.3%) |
Sep 2015 | - | $5.94 B(+8.6%) | $21.91 B(+4.4%) |
Jun 2015 | - | $5.47 B(+8.6%) | $20.99 B(+2.7%) |
Mar 2015 | - | $5.04 B(-7.6%) | $20.44 B(+2.4%) |
Dec 2014 | $19.96 B(+6.2%) | $5.45 B(+8.6%) | $19.96 B(+1.7%) |
Sep 2014 | - | $5.02 B(+1.9%) | $19.62 B(+1.9%) |
Jun 2014 | - | $4.93 B(+8.0%) | $19.26 B(+1.2%) |
Mar 2014 | - | $4.56 B(-10.7%) | $19.02 B(+1.2%) |
Dec 2013 | $18.79 B(+2.2%) | $5.11 B(+9.7%) | $18.79 B(-0.5%) |
Sep 2013 | - | $4.66 B(-0.7%) | $18.89 B(+0.8%) |
Jun 2013 | - | $4.69 B(+8.4%) | $18.73 B(+1.1%) |
Mar 2013 | - | $4.33 B(-16.8%) | $18.54 B(+0.8%) |
Dec 2012 | $18.38 B(+5.4%) | $5.21 B(+15.5%) | $18.38 B(+1.9%) |
Sep 2012 | - | $4.51 B(+0.3%) | $18.04 B(+0.6%) |
Jun 2012 | - | $4.49 B(+7.7%) | $17.94 B(+1.2%) |
Mar 2012 | - | $4.17 B(-14.2%) | $17.72 B(+1.6%) |
Dec 2011 | $17.44 B(+11.5%) | $4.86 B(+10.3%) | $17.44 B(+38.7%) |
Sep 2011 | - | $4.41 B(+3.1%) | $12.58 B(+54.0%) |
Jun 2011 | - | $4.27 B(+9.7%) | $8.17 B(+109.7%) |
Mar 2011 | - | $3.90 B | $3.90 B |
Dec 2010 | $15.64 B(+10.0%) | - | - |
Dec 2009 | $14.21 B | - | - |
FAQ
- What is AbbVie annual revenue?
- What is the all time high annual revenue for AbbVie?
- What is AbbVie annual revenue year-on-year change?
- What is AbbVie quarterly revenue?
- What is the all time high quarterly revenue for AbbVie?
- What is AbbVie quarterly revenue year-on-year change?
- What is AbbVie TTM revenue?
- What is the all time high TTM revenue for AbbVie?
- What is AbbVie TTM revenue year-on-year change?
What is AbbVie annual revenue?
The current annual revenue of ABBV is $56.33 B
What is the all time high annual revenue for AbbVie?
AbbVie all-time high annual revenue is $58.05 B
What is AbbVie annual revenue year-on-year change?
Over the past year, ABBV annual revenue has changed by +$2.02 B (+3.71%)
What is AbbVie quarterly revenue?
The current quarterly revenue of ABBV is $15.10 B
What is the all time high quarterly revenue for AbbVie?
AbbVie all-time high quarterly revenue is $15.12 B
What is AbbVie quarterly revenue year-on-year change?
Over the past year, ABBV quarterly revenue has changed by +$642.00 M (+4.44%)
What is AbbVie TTM revenue?
The current TTM revenue of ABBV is $56.33 B
What is the all time high TTM revenue for AbbVie?
AbbVie all-time high TTM revenue is $58.05 B
What is AbbVie TTM revenue year-on-year change?
Over the past year, ABBV TTM revenue has changed by +$801.00 M (+1.44%)